Skip to main content
    I

    IO Biotech Inc (IOBT)

    Official site

    BIOTECHNOLOGY

    $0.05
    +0.00 (+0.00%)

    Last updated: Apr 07, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(9/16)
    Avg Surprise
    -1.53%
    Streak
    1 Q
    Last 12 of 22 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 25
    Reported Mar 4
    Not reported-$0.21N/A-----
    Sep 25
    Reported Nov 7
    -$0.25-$0.35N/A+27.59%Beat1
    No revisions (30d)
    +30.6%
    Jun 25
    Reported Aug 14
    -$0.40-$0.37N/A-8.11%Miss1
    No revisions (30d)
    -29.0%
    Mar 25
    Reported May 14
    -$0.34-$0.31N/A-9.68%Miss1
    No revisions (30d)
    -13.3%
    Dec 24
    Reported Mar 27
    -$0.48-$0.31N/A-53.60%Miss---20.0%
    Sep 24
    Reported Nov 12
    -$0.36-$0.29-$0.35 - -$0.20-24.14%Miss4
    No revisions (30d)
    +16.3%
    Jun 24
    Reported Aug 13
    -$0.31-$0.34-$0.36 - -$0.34+8.82%Beat3
    No revisions (30d)
    +58.1%
    Mar 24
    Reported May 14
    -$0.30-$0.36-$0.40 - -$0.32+16.67%Beat4
    No revisions (30d)
    +49.2%
    Dec 23
    Reported Mar 5
    -$0.40-$0.39N/A-2.56%Miss--+42.9%
    Sep 23
    Reported Nov 13
    -$0.43-$0.44-$0.85 - -$0.31+2.27%Beat5
    No revisions (30d)
    +23.2%
    Jun 23
    Reported Aug 11
    -$0.74-$0.66-$0.69 - -$0.64-12.12%Miss3
    No revisions (30d)
    -15.6%
    Mar 23
    Reported May 11
    -$0.59-$0.70-$0.74 - -$0.66+15.71%Beat4
    No revisions (30d)
    +1.7%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 81.8% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 23.8, below 30, the oversold line.

    Moving Averages

    SMA 10$0.12
    SMA 20$0.16
    SMA 50$0.26
    SMA 200$0.94
    EMA 10$0.10
    EMA 20$0.16
    EMA 50$0.28
    EMA 200$0.70

    MACD

    Line: -0.07Signal: -0.06Hist: -0.01

    ADX

    ADX: 44.1+DI: 11.0-DI: 41.3

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$0.11

    Bollinger Bands

    Upper Band$0.31
    Lower Band$0.02
    %B Position17926%(Upper)
    Band Width0.11

    RSI (14-Day)

    Oversold
    23.8

    Momentum Oscillators

    Stoch %K7.8
    Stoch %D6.3
    Williams %R-89.4
    ROC (10d)-77.0%
    Momentum-0.16
    CCI (20d)-128.6
    MFI (14d)75.7

    Volatility Measures

    ATR (14d)$0.03(70.6%)
    StdDev (20d)0.07
    Hist Vol336.7%(High)

    Volume Flow

    VWAP$0.05
    OBV744.2M
    AD Line395.9M
    CMF (20d)0.442

    Volume Metrics

    Avg Vol (20d)33.0M
    Vol RatioN/A
    VWMA (20d)$0.06

    Pivot Points

    R3$0.09
    R2$0.07
    R1$0.06
    Pivot Point$0.04
    S1$0.03
    S2$0.02
    S3$0.00

    Advanced Oscillators

    TSI-47.93
    Ultimate Osc29.4
    KST-584.97

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about IOBT

    News

    No news available

    Company news will appear here when available

    IO Biotech Competitors

    Peers by sector and size for IO Biotech (IOBT) include Healthcare Triangle, Neurosense Therapeutics and Vivos Therapeutics.

    Sector: Healthcare

    IOBT Bull Case vs Bear Case

    Bear case

    • IOBT beat EPS estimates in 37.5% of its last 8 reported quarters.

    IOBT Earnings: Beat Rate

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -5.6%

    Updated Mar 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.